Robert J. Spiegel, Chief Medical Officer at PTC THERAPEUTICS, INC. (PTCT), sold 1,186 shares at $31.75 ($38K) on 2014-03-13, disclosed to the SEC on 2014-03-14.
Scheduled sale ($38k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTCT | SELL | 2015-03-13 | $77K | — | Filing → |